503Pharma Weekly Compounding Pharmacy Roundup

News and Regulatory Updates

1. FDA Approves First Oral GLP-1 Pill for Obesity: Novo Nordisk's oral semaglutide (Wegovy pill) gained FDA approval as the first oral GLP-1 for chronic weight management and cardiovascular risk reduction in adults with obesity. It launched broadly in the U.S. in early January 2026.

   • Novo Nordisk Press Release (Jan 5, 2026)
     

2. Bipartisan SAFE Drugs Act Introduced: Reps. Rudy Yakym (R-IN) and André Carson (D-IN) introduced H.R.6509, the SAFE Drugs Act of 2025, to strengthen compounding oversight—including clearer "essentially a copy" definitions, out-of-state shipping reports, and stricter inspections/cGMP requirements.

   • Summary and Support (AIMED Alliance)

Request Formulas Now in our New Members Area!

Plus:

• Community Discussion Forum — Connect with peers, ask questions, and share insights on compounding, compliance, business operations, and industry news

• Professional Profiles — Build your profile with your credentials, specialty areas, and organization to connect with the right people

• Direct Messaging — Have private conversations with other members in the community

👉 https://app.503pharma.com

Grow your Pharmacy and Peptides Business:

Beyond formulas and compounding education, we've started helping pharmacies with prescriber outreach—the marketing side of growing your script volume, especially for peptides. Two offerings:

1. Marketing Materials: Custom brochures, presentations, and videos to use when meeting with clinics.

2. Prescriber Pipeline: We handle outreach on your behalf—research clinics, reach out, and schedule meetings directly on your calendar.

👉 https://growth.503pharma.com

CompoundLearn is LIVE!

CompoundLearn was built to simplify USP <795>, <797>, and <800> training—and keep you inspection-ready.

• Full access to 25 training modules and 77 lessons covering critical USP 795, 797, and 800 topics

• Role-based assignments — assign and track the right training curriculum to designated persons/pharmacists-in-charge, compounders, and trainers

• Quizzes that prove that your team knows the material

• Downloadable certificates for your training records

👉 https://app.compoundlearn.com/

✉️ That’s your 503Pharma weekly digest. Our mission is to keep compounding professionals informed, prepared, and ahead of the curve.